Abstract:Background: Cancer is one of the most common life-threatening diseases worldwide; many patients develop multidrug resistance after treatment with anticancer drugs. The main mechanism leading to multidrug resistance is the overexpression of ABC transporters in cancer cells. Chemosensitizers are needed to inhibit the activity of ABC transporters, resulting in higer intracellular concentration of anticancer drugs. Some secondary metabolites have been reported to be chemosensitizers by inhibiting ABC transporters. Epigallocatechin gallate (EGCG), tannic acid, and curcumin were employed in this study. Different assays were used to detect whether they have the ability to inhibit P-gp activity and overcome multidrug resistance in cancer cells overexpressing P-gp. Hypothesis/Purpose: CEM/ADR 5000 and Caco-2 cell lines, which overexpress P-gp, are multidrug resistant cell lines. We first detected whether the combination of polyphenols (EGCG, tannic acid, curcumin) and doxorubicin, an anticancer drug, is synergistic or not. To further understand the potential mechanism, EGCG, tannic acid, and curcumin were tested to check whether they have the ability to inhibit P-gp activity. When P-gp activity is inhibited, the intracellular concentration of doxorubicin is higher, resulting in enhanced cytotoxicity of doxorubicin. Study design: The P-gp overexpressing human colon cancer cell line Caco-2 and human T-lymphoblastic leukemia cell line CEM/ADR 5000 were used in this study. Two-drug combinations (doxorubicin + polyphenol) and three-drug combinations (doxorubicin + polyphenol + digitonin) were tested to examine potential synergism. The potential mechanism leading to synergism would be the inhibition of P-gp activity. A Rhodamine 123 assay and Calcein-AM assay in Caco-2 and CEM/ADR 5000, respectively, were used to detect P-gp inhibition by EGCG, curcumin, and tannic acid. Methods: MTT assay was used to determine the cytotoxicity of doxorubicin, polyphenols and digitonin alone, and then their combinations. Furthermore, Rhodamine 123 and Calcein-AM were used to detect the effects of polyphenols on the activity of P-gp. Results: The results demonstrated that a combination of non-toxic concentrations of each polyphenol with doxorubicin synergistically sensitized Caco-2 and CEM/ADR 5000 cells. Furthermore, three-drug combinations (doxorubicin + polyphenol + digitonin) were much more effective. In addition, the activity of P-gp in Caco-2 and CEM/ADR 5000 cells was measured. Consistent with the combination results, tannic acid and curcumin decreased the activity of P-gp both in Caco-2 and CEM/ADR 5000. EGCG, which weakly affected the activity of P-gp in CEM/ADR 5000, only had an effect on P-gp under higher concentration in Caco-2 cells. Conclusion: Our results show that EGCG, curcumin, and tannic acid, when combined with doxorubicin, can exert synergism, mediated by a reduced activity of P-gp. This study suggests that polyphenols, by modulating the activity of P-gp, may be used as chemosensitisers.

Curcumin Prevents Induced Drug Resistance: A Novel Function?

Identification of Curcumin As a Novel Natural Inhibitor of Rdna Transcription.

[Empirical Study of Reverse Effect on Mediated Multidrug Resistance of U-2OS/ADM Cells with Curcumin in Vitro].

Ancient Drug Curcumin Impedes 26S Proteasome Activity by Direct Inhibition of Dual-Specificity Tyrosine-Regulated Kinase 2

Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level

Reverse Effect of Curcumin on CDDP-induced Drug-Resistance Via Keap1/p62-Nrf2 Signaling in A549/CDDP Cell.

Liposomal Curcumin Alters Chemosensitivity of Breast Cancer Cells to Adriamycin Via Regulating Microrna Expression.

Reversal in Multidrug Resistance by Magnetic Nanoparticle of Fe3o4 Loaded with Adriamycin and Tetrandrine in K562/A02 Leukemic Cells

Effect of curcumin on P-glycoprotein activity and expression of MDR1 gene mRNA in Caco-2 cells

Mechanism of Reversal of Multidrug Resistance by Curcumin in Human Colorectal Cancer Cell Line HCT-8/5-FU

Nrf2 is a Key Factor in the Reversal Effect of Curcumin on Multidrug Resistance in the HCT‑8/5‑Fu Human Colorectal Cancer Cell Line

Reversal of multidrug resistance in human breast cancer cells by Curcuma wenyujin and Chrysanthemum indicum

Reversal Effect of Curcumin on P-gp Mediated Bladder Tumor Multidrug-resisitance in Cell Line BIU-87/ADR

Reversion of Drug Resistance in a Hepatocellular Carcinoma by Curcumine in Ivtro

The enhanced inhibitory effects of curcumin combined with adriamycin on the growth of human leukemia cell line HL-60/ADR with multidrug resistance

Curcumin reverses multidrug resistance of human hepatocellular carcinoma bel7402/5-FU cells

Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells.

Synthetic Analogs of Curcumin Modulate the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCG2

Antitumor effects of curcumin combining with adriamycin in vitro

Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.

[Reversing Effects of Curcumin on Multi-Drug Resistance of Bel7402/5-fu Cell Line].